6-150389486-TTCA-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM4_SupportingPP5
The NM_203395.3(IYD):c.315_317del(p.Phe105_Ile106delinsLeu) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 0 hom. )
Consequence
IYD
NM_203395.3 inframe_deletion
NM_203395.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.35
Genes affected
IYD (HGNC:21071): (iodotyrosine deiodinase) This gene encodes an enzyme that catalyzes the oxidative NADPH-dependent deiodination of mono- and diiodotyrosine, which are the halogenated byproducts of thyroid hormone production. The N-terminus of the protein functions as a membrane anchor. Mutations in this gene cause congenital hypothyroidism due to dyshormonogenesis type 4, which is also referred to as deiodinase deficiency, or iodotyrosine dehalogenase deficiency, or thyroid hormonogenesis type 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
In a mutagenesis_site Activity as the wild type. (size 0) in uniprot entity IYD1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_203395.3. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 6-150389486-TTCA-T is Pathogenic according to our data. Variant chr6-150389486-TTCA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 738.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IYD | NM_203395.3 | c.315_317del | p.Phe105_Ile106delinsLeu | inframe_deletion | 2/5 | ENST00000344419.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IYD | ENST00000344419.8 | c.315_317del | p.Phe105_Ile106delinsLeu | inframe_deletion | 2/5 | 1 | NM_203395.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
24
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251400Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135872
GnomAD3 exomes
AF:
AC:
26
AN:
251400
Hom.:
AF XY:
AC XY:
15
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000259 AC: 379AN: 1461798Hom.: 0 AF XY: 0.000249 AC XY: 181AN XY: 727204
GnomAD4 exome
AF:
AC:
379
AN:
1461798
Hom.:
AF XY:
AC XY:
181
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74338
GnomAD4 genome
AF:
AC:
24
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Iodotyrosine deiodination defect Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 24, 2008 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 01, 2021 | - - |
IYD-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 13, 2023 | The IYD c.315_317delCAT variant is predicted to result in an in-frame deletion (p.Phe105_Ile106delinsLeu). This variant was reported in two homozygous individuals with goitrous hypothyroidism (Moreno et al. 2008. PubMed ID: 18434651). This variant is reported in 0.022% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-150710622-TTCA-T). This variant is interpreted as likely pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2021 | The c.315_317delCAT (p.F105_I106delinsL) alteration is located in exon 2 (coding exon 2) of the IYD gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.315 and c.317, resulting in the deletion of 1 residue. The p.F105_I106delinsL alteration is predicted to be deleterious with a score of -10.5 by PROVEAN in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at